Jennifer Zarcone, Ph.D., BCBA

Dr. Jennifer Zarcone
Jennifer Zarcone
Senior Behavior Analyst, Neurobehavioral Unit (NBU)

Kennedy Krieger Institute
707 N. Broadway
Baltimore, MD 21205
Phone: (443) 923-2925
Email: zarcone@kennedykrieger.org

Jennifer Zarcone is a Senior Behavior Analyst on the Neurobehavioral Unit in Behavioral Psychology and an Associate Professor in the Department of Psychiatry and Behavioral Sciences. She is a supervising clinician and researcher for individuals with disabilities who have severe problem behavior.


Biographical Sketch:

Dr. Zarcone obtained her doctoral degree from the Behavior Analysis program at the University of Florida, Department of Psychology in 1993. She is a board certified behavior analyst and a licensed psychologist. She has served in leadership positions on the Board of Directors for the Association for Positive Behavior Support. For the Association of Behavior Analysis (ABAI) she serves on the Practice Board and as a conference coordinator for the annual Autism Conference. She completed a three year term as an associate editor for the Journal of Applied Behavior Analysis and serves on the board of editors for the American Journal on Intellectual and Developmental Disabilities and the International Journal of Developmental Disabilities. She is currently on the board of the Maryland Association for Behavior Analysis. Her areas of expertise are in autism, severe behavior disorders, and medication clinical trials.


Research Summary:

Dr. Zarcone has obtained NIH grant funding in the areas of functional analysis and clinical trials, as well as evaluating neuroanatomical functioning associated with hyperphagia in people with Prader-Willi syndrome. She has served as a co-investigator on several multi-center clinical trials in autism research at the University of Rochester Medical Center and at the Kennedy Krieger Institute and is currently collaborating with colleagues at Kennedy Krieger on grants related to severe self-injury. She is interested in further development of research in the effects of pharmacological and behavioral interventions in the treatment of severe behavior disorders as well as repetitive behavior disorders in individuals with autism.